RetinalGeniX Technologies has received a patent for its patient home monitoring and integrated physician alert system for ocular anatomy.
Designed to send an alert to a physician located remotely, the invention pertains to a home monitoring device installed at the patient’s residence.
Go deeper with GlobalData
The physician can then conduct a preliminary evaluation from a distance to determine if an in-person medical diagnosis is necessary.
In conjunction with RetinalGeniX’s DNA/GPS technology, the new patented system is expected to assist in the early diagnosis of systemic diseases by deploying high-resolution remote retinal imaging and real-time monitoring from the home.
According to the company, the existing eye care model, where patients need to schedule in-person visits with eye specialists, has multiple drawbacks.
The company also stated that over 500 million people globally experience severe eye conditions but a sufficient number of ophthalmologists and optometrists are not available in the US and worldwide for screening, examining, diagnosing and treating these diabetic patients.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataRetinalGeniX believes that it is crucial to establish a remote health monitoring system, which would empower patients to oversee their well-being from a distance, eliminating the need for frequent in-person office visits for screenings or non-diagnostic evaluations.
This ensures that patients can conveniently manage their health from the comfort of their own homes, free from any inconvenience.
RetinalGeniX CEO Jerry Katzman said: “The current diagnostic process is neither timely nor cost-effective if a patient cannot physically visit the emergency room, doctor’s office or laboratory.
“RetinalGeniX is leading the charge in embracing this paradigm shift and we fully expect the imminent emergence of pharmaco-genetic mapping enhanced home diagnostics.”
